Basal Cell Carcinoma (BCC) Recruiting Phase 2 Trials for Darleukin (DB17157)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

IndicationStatusPhase
DBCOND0040396 (Basal Cell Carcinoma (BCC))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05329792L19IL2/L19TNF in Skin Cancer PatientsTreatment
NCT04362722Intratumoral Administration of Daromun in Non-melanoma Skin Cancer PatientsTreatment